Changes in slow-wave sleep characteristics in Parkinson’s disease patients with depression
Objective: This study used polysomnography (PSG) to examine the relationship between depression in PD and sleep characteristics, particularly (SWA). Background: Depression and sleep disturbance is…Phenomenology of Functional Movement Disorders in Children
Objective: To study the phenomenology of Functional Movement Disorders (FMD) in children. Background: Data on FMD in children is sparse Method: The study included 13…Untangling Bidirectional Influences of Somatic and Internalizing Symptoms among People with Parkinson’s Disease: A Retrospective Cohort Study
Objective: Among patients with PD, determine if there is a bidirectional association between severity of somatic & internalizing symptoms over 3 years. Background: Among people…An Investigation of Quality of Life for Caretakers of Parkinson’s Disease Patients in Indian Villages
Objective: The objective of this research is to measure the burden and depression experienced by caregivers and the factors related to it among individuals diagnosed…Clinical Predictors of Impulse Control Disorders in Parkinson’s Disease
Objective: To investigate whether anxiety, depression, and sleep impairment relate to development of impulse control disorders (ICD) in patients with early-stage Parkinson’s disease (PD). Background:…Perceptions of Diseases in Patients with Cervical Dystonia
Objective: To explore how perception of disease can impact stigma, mood, quality of life, and severity of symptoms in patients with cervical dystonia (CD). Background:…Longitudinal patterns of Anxiety and Depression in patients with Parkinson’s Disease
Objective: To analyze longitudinal trends of severity of anxiety and depression in a large Parkinson’s Disease (PD) cohort Background: •Depression and anxiety are common non…Parkinson’s Disease Clinical Subtypes Differ in Health-Related QOL
Objective: To determine whether clinical subtypes of Parkinson disease (PD) differ in health-related quality of life (QOL). Background: Health-related QOL varies for individuals with PD.…Psilocybin therapy for depression and anxiety associated with Parkinson’s disease: a pilot study (NCT04932434)
Objective: To investigate the safety, tolerability, feasibility, and preliminary efficacy of moderate and high dose psilocybin treatment with psychotherapeutic support for comorbid Parkinson's disease (PD)…Habenula Volume in Mood Disorders in Parkinson’s Disease
Objective: To assess whether dysregulation of habenula (Hb) contributes to mood disorders in Parkinson’s disease (PD). Background: PD is often accompanied by mood disorders, such…
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 36
- Next Page »